These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
507 related articles for article (PubMed ID: 34556273)
1. 5-Year Outcomes Comparing Surgical Versus Transcatheter Aortic Valve Replacement in Patients With Chronic Kidney Disease. Garcia S; Cubeddu RJ; Hahn RT; Ternacle J; Kapadia SR; Kodali SK; Thourani VH; Jaber WA; Asher CR; Elmariah S; Makkar R; Webb JG; Herrmann HC; Lu M; Devireddy CM; Malaisrie SC; Smith CR; Mack MJ; Sorajja P; Cavalcante JL; Goessl M; Shroff GR; Leon MB; Pibarot P JACC Cardiovasc Interv; 2021 Sep; 14(18):1995-2005. PubMed ID: 34556273 [TBL] [Abstract][Full Text] [Related]
2. Structural Deterioration of Transcatheter Versus Surgical Aortic Valve Bioprostheses in the PARTNER-2 Trial. Pibarot P; Ternacle J; Jaber WA; Salaun E; Dahou A; Asch FM; Weissman NJ; Rodriguez L; Xu K; Annabi MS; Guzzetti E; Beaudoin J; Bernier M; Leipsic J; Blanke P; Clavel MA; Rogers E; Alu MC; Douglas PS; Makkar R; Miller DC; Kapadia SR; Mack MJ; Webb JG; Kodali SK; Smith CR; Herrmann HC; Thourani VH; Leon MB; Hahn RT; J Am Coll Cardiol; 2020 Oct; 76(16):1830-1843. PubMed ID: 33059828 [TBL] [Abstract][Full Text] [Related]
3. Outcomes of SAPIEN 3 Transcatheter Aortic Valve Replacement Compared With Surgical Valve Replacement in Intermediate-Risk Patients. Madhavan MV; Kodali SK; Thourani VH; Makkar R; Mack MJ; Kapadia S; Webb JG; Cohen DJ; Herrmann HC; Williams M; Greason K; Pibarot P; Hahn RT; Jaber W; Xu K; Alu M; Smith CR; Leon MB J Am Coll Cardiol; 2023 Jul; 82(2):109-123. PubMed ID: 37407110 [TBL] [Abstract][Full Text] [Related]
4. Effect of SAPIEN 3 Transcatheter Valve Implantation on Health Status in Patients With Severe Aortic Stenosis at Intermediate Surgical Risk: Results From the PARTNER S3i Trial. Baron SJ; Thourani VH; Kodali S; Arnold SV; Wang K; Magnuson EA; Pichard AD; Babaliaros V; George I; Miller DC; Tuzcu EM; Greason K; Herrmann HC; Smith CR; Leon MB; Cohen DJ; JACC Cardiovasc Interv; 2018 Jun; 11(12):1188-1198. PubMed ID: 29860075 [TBL] [Abstract][Full Text] [Related]
5. Echocardiographic Results of Transcatheter Versus Surgical Aortic Valve Replacement in Low-Risk Patients: The PARTNER 3 Trial. Pibarot P; Salaun E; Dahou A; Avenatti E; Guzzetti E; Annabi MS; Toubal O; Bernier M; Beaudoin J; Ong G; Ternacle J; Krapf L; Thourani VH; Makkar R; Kodali SK; Russo M; Kapadia SR; Malaisrie SC; Cohen DJ; Leipsic J; Blanke P; Williams MR; McCabe JM; Brown DL; Babaliaros V; Goldman S; Szeto WY; Généreux P; Pershad A; Alu MC; Xu K; Rogers E; Webb JG; Smith CR; Mack MJ; Leon MB; Hahn RT; Circulation; 2020 May; 141(19):1527-1537. PubMed ID: 32272848 [TBL] [Abstract][Full Text] [Related]
6. Clinical impact of baseline chronic kidney disease in patients undergoing transcatheter or surgical aortic valve replacement. Pineda AM; Kevin Harrison J; Kleiman NS; Reardon MJ; Conte JV; O'Hair DP; Chetcuti SJ; Huang J; Yakubov SJ; Popma JJ; Beohar N Catheter Cardiovasc Interv; 2019 Mar; 93(4):740-748. PubMed ID: 30341970 [TBL] [Abstract][Full Text] [Related]
7. Cost-Effectiveness of Transcatheter Versus Surgical Aortic Valve Replacement in Patients With Severe Aortic Stenosis at Intermediate Risk. Baron SJ; Wang K; House JA; Magnuson EA; Reynolds MR; Makkar R; Herrmann HC; Kodali S; Thourani VH; Kapadia S; Svensson L; Mack MJ; Brown DL; Russo MJ; Smith CR; Webb J; Miller C; Leon MB; Cohen DJ Circulation; 2019 Feb; 139(7):877-888. PubMed ID: 30586747 [TBL] [Abstract][Full Text] [Related]
8. Prosthesis-Patient Mismatch After Aortic Valve Replacement in the PARTNER 2 Trial and Registry. Ternacle J; Pibarot P; Herrmann HC; Kodali S; Leipsic J; Blanke P; Jaber W; Mack MJ; Clavel MA; Salaun E; Guzzetti E; Annabi MS; Bernier M; Beaudoin J; Khalique OK; Weissman NJ; Douglas P; Bax J; Dahou A; Xu K; Alu M; Rogers E; Leon M; Thourani VH; Abbas AE; Hahn RT JACC Cardiovasc Interv; 2021 Jul; 14(13):1466-1477. PubMed ID: 34238557 [TBL] [Abstract][Full Text] [Related]
9. Mid-term outcomes of Sapien 3 versus Perimount Magna Ease for treatment of severe aortic stenosis. Virtanen MPO; Eskola M; Savontaus M; Juvonen T; Niemelä M; Laakso T; Husso A; Jalava MP; Tauriainen T; Ahvenvaara T; Maaranen P; Kinnunen EM; Dahlbacka S; Laine M; Mäkikallio T; Valtola A; Raivio P; Rosato S; D'Errigo P; Vento A; Airaksinen J; Biancari F J Cardiothorac Surg; 2020 Jun; 15(1):157. PubMed ID: 32600369 [TBL] [Abstract][Full Text] [Related]
10. Transcatheter Versus Surgical Aortic Valve Replacement in Patients With Prior Cardiac Surgery in the Randomized PARTNER 2A Trial. Chen S; Redfors B; Ben-Yehuda O; Crowley A; Greason KL; Alu MC; Finn MT; Vahl TP; Nazif T; Thourani VH; Suri RM; Svensson L; Webb JG; Kodali SK; Leon MB JACC Cardiovasc Interv; 2018 Nov; 11(21):2207-2216. PubMed ID: 30409278 [TBL] [Abstract][Full Text] [Related]
11. Impact of Flow on Prosthesis-Patient Mismatch Following Transcatheter and Surgical Aortic Valve Replacement. Abbas AE; Ternacle J; Pibarot P; Xu K; Alu M; Rogers E; Hahn RT; Leon M; Thourani VH Circ Cardiovasc Imaging; 2021 Aug; 14(8):e012364. PubMed ID: 34387097 [TBL] [Abstract][Full Text] [Related]
12. Doppler Velocity Index Outcomes Following Surgical or Transcatheter Aortic Valve Replacement in the PARTNER Trials. Hahn RT; Douglas PS; Jaber WA; Leipsic J; Kapadia S; Thourani VH; Makkar R; Kodali S; Clavel MA; Khalique OK; Weissman NJ; Blanke P; Chen Y; Smith CR; Mack MJ; Leon MB; Pibarot P JACC Cardiovasc Interv; 2021 Jul; 14(14):1594-1606. PubMed ID: 34217631 [TBL] [Abstract][Full Text] [Related]
13. Outcomes of intermediate-risk patients treated with transcatheter and surgical aortic valve replacement in the Veterans Affairs Healthcare System: A single center 20-year experience. Garcia S; Kelly R; Mbai M; Gurevich S; Oestreich B; Yannopoulos D; Adabag S Catheter Cardiovasc Interv; 2018 Aug; 92(2):390-398. PubMed ID: 29316204 [TBL] [Abstract][Full Text] [Related]
14. Economic Outcomes of Transcatheter Versus Surgical Aortic Valve Replacement in Patients with Severe Aortic Stenosis and Low Surgical Risk: Results from the PARTNER 3 Trial. Galper BZ; Chinnakondepalli KM; Wang K; Magnuson EA; Lu M; Thourani VH; Kodali S; Makkar R; Herrmann HC; Kapadia S; Williams M; Webb J; Smith CR; Mack MJ; Leon MB; Cohen DJ; Circulation; 2023 May; 147(21):1594-1605. PubMed ID: 37154049 [TBL] [Abstract][Full Text] [Related]
15. Durability of Transcatheter and Surgical Bioprosthetic Aortic Valves in Patients at Lower Surgical Risk. Søndergaard L; Ihlemann N; Capodanno D; Jørgensen TH; Nissen H; Kjeldsen BJ; Chang Y; Steinbrüchel DA; Olsen PS; Petronio AS; Thyregod HGH J Am Coll Cardiol; 2019 Feb; 73(5):546-553. PubMed ID: 30732707 [TBL] [Abstract][Full Text] [Related]
16. Health Status Benefits of Transcatheter vs Surgical Aortic Valve Replacement in Patients With Severe Aortic Stenosis at Intermediate Surgical Risk: Results From the PARTNER 2 Randomized Clinical Trial. Baron SJ; Arnold SV; Wang K; Magnuson EA; Chinnakondepali K; Makkar R; Herrmann HC; Kodali S; Thourani VH; Kapadia S; Svensson L; Brown DL; Mack MJ; Smith CR; Leon MB; Cohen DJ; JAMA Cardiol; 2017 Aug; 2(8):837-845. PubMed ID: 28658491 [TBL] [Abstract][Full Text] [Related]
17. Transcatheter aortic valve replacement versus surgical valve replacement in intermediate-risk patients: a propensity score analysis. Thourani VH; Kodali S; Makkar RR; Herrmann HC; Williams M; Babaliaros V; Smalling R; Lim S; Malaisrie SC; Kapadia S; Szeto WY; Greason KL; Kereiakes D; Ailawadi G; Whisenant BK; Devireddy C; Leipsic J; Hahn RT; Pibarot P; Weissman NJ; Jaber WA; Cohen DJ; Suri R; Tuzcu EM; Svensson LG; Webb JG; Moses JW; Mack MJ; Miller DC; Smith CR; Alu MC; Parvataneni R; D'Agostino RB; Leon MB Lancet; 2016 May; 387(10034):2218-25. PubMed ID: 27053442 [TBL] [Abstract][Full Text] [Related]